Senior Vice President
Clinical Research and Development
Dr. Per Cantor joined Ferring in July 2006 and is responsible for global clinical and pre-clinical research. Prior to joining Ferring, Per held various leadership positions within R&D during a 15 year career at Eli Lilly in both Europe and the United States. He holds a MD and a PhD degree in the field of peptide hormones from the University of Copenhagen as well as a Bachelor of Commerce degree from Copenhagen Business School.
He is responsible for the global clinical and pre clinical research and development in the pharamceutical industries.